News tagged with relenza

Beware fake flu treatments, FDA warns

(HealthDay)—With the height of flu season here, the U.S Food and Drug Administration warns consumers to avoid fraudulent products that claim to prevent, treat or cure the flu.

Feb 04, 2013
popularity0 comments 0

Sorry, no news articles match your request. Your search criteria may be too narrow.

Zanamivir

Zanamivir (INN) (pronounced /zəˈnæmɨvɪr/) is a neuraminidase inhibitor used in the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza.

This text uses material from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed